Literature DB >> 3600769

The X-linked chronic granulomatous disease gene codes for the beta-chain of cytochrome b-245.

C Teahan, P Rowe, P Parker, N Totty, A W Segal.   

Abstract

Chronic granulomatous disease (CGD) is a rare inherited disorder associated with a profound predisposition to infection due to the lack of a microbicidal oxidase system in the phagocytes of these patients. This syndrome is most commonly inherited through a defect on the X chromosome and the only clearly defined component of the oxidase system, the very unusual cytochrome b (b-245), has been shown to be missing from the cells of these patients. This cytochrome is a heterodimer composed of an alpha-chain of relative molecular mass (Mr) 23,000 (23K) and a 76-92K beta-chain; neither are detectable in neutrophils from X-linked CGD subjects. The defective X-CGD gene has recently been cloned by 'reverse genetics' but the protein predicted from the proposed complementary DNA sequence was not identified. We have purified the beta-chain of the cytochrome and sequenced 43 amino acids from the N terminus. Almost complete homology was obtained between this sequence and that of the complementary nucleotides 19-147 of the sequence of the X-CGD gene, originally designated as a non-coding region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3600769     DOI: 10.1038/327720a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  73 in total

Review 1.  Higher-plant plasma membrane cytochrome b561: a protein in search of a function.

Authors:  H Asard; J Kapila; W Verelst; A Bérczi
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  Localization of Nox2 N-terminus using polyclonal antipeptide antibodies.

Authors:  Marie-Hélène Paclet; Lydia M Henderson; Yannick Campion; Françoise Morel; Marie-Claire Dagher
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

3.  Isolation and characterization of grancalcin, a novel 28 kDa EF-hand calcium-binding protein from human neutrophils.

Authors:  C G Teahan; N F Totty; A W Segal
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

4.  Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.

Authors:  Michael Nardi; Steven J Feinmark; Liang Hu; Zongdong Li; Simon Karpatkin
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 5.  The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.

Authors:  A W Segal
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

6.  Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease.

Authors:  S E Caldwell; C E McCall; C L Hendricks; P A Leone; D A Bass; L C McPhail
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.

Authors:  M C Dinauer; J T Curnutte; H Rosen; S H Orkin
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.

Authors:  L M Henderson; J B Chappell; O T Jones
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 9.  Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease.

Authors:  S Umeki
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

10.  A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Authors:  J H Leusen; M de Boer; B G Bolscher; P M Hilarius; R S Weening; H D Ochs; D Roos; A J Verhoeven
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.